All In MedTech

FDA Clearance Tracker · P850020-S013

PROSORBA COLUMN

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 26, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 26, 2001

Approved

Time to decision

179 days

Received Apr 30, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Unclassified

The decision

FDA number
P850020-S013
Device name
PROSORBA COLUMN
Applicant location
Waltham, MA
Received
Apr 30, 2001
Decided
Oct 26, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P850020

Device type

Device class
Unclassified

Every decision under product code LKN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR REVISED LABELING THAT RELATES NEW POST-MARKET SAFETY INFORMATION REGARDING EPISODES OF VASCULITIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH THE PROSORBA(R) COLUMN.

Source documents

Other decisions for Fresenius Hemocare, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.